Loss of glutathione redox homeostasis impairs proteostasis by inhibiting autophagy-dependent protein degradation.


Journal

Cell death and differentiation
ISSN: 1476-5403
Titre abrégé: Cell Death Differ
Pays: England
ID NLM: 9437445

Informations de publication

Date de publication:
09 2019
Historique:
received: 26 06 2018
accepted: 20 12 2018
revised: 04 12 2018
pubmed: 17 2 2019
medline: 29 7 2020
entrez: 17 2 2019
Statut: ppublish

Résumé

In the presence of aggregation-prone proteins, the cytosol and endoplasmic reticulum (ER) undergo a dramatic shift in their respective redox status, with the cytosol becoming more oxidized and the ER more reducing. However, whether and how changes in the cellular redox status may affect protein aggregation is unknown. Here, we show that C. elegans loss-of-function mutants for the glutathione reductase gsr-1 gene enhance the deleterious phenotypes of heterologous human, as well as endogenous worm aggregation-prone proteins. These effects are phenocopied by the GSH-depleting agent diethyl maleate. Additionally, gsr-1 mutants abolish the nuclear translocation of HLH-30/TFEB transcription factor, a key inducer of autophagy, and strongly impair the degradation of the autophagy substrate p62/SQST-1::GFP, revealing glutathione reductase may have a role in the clearance of protein aggregates by autophagy. Blocking autophagy in gsr-1 worms expressing aggregation-prone proteins results in strong synthetic developmental phenotypes and lethality, supporting the physiological importance of glutathione reductase in the regulation of misfolded protein clearance. Furthermore, impairing redox homeostasis in both yeast and mammalian cells induces toxicity phenotypes associated with protein aggregation. Together, our data reveal that glutathione redox homeostasis may be central to proteostasis maintenance through autophagy regulation.

Identifiants

pubmed: 30770874
doi: 10.1038/s41418-018-0270-9
pii: 10.1038/s41418-018-0270-9
pmc: PMC6748101
doi:

Substances chimiques

Amyloid beta-Peptides 0
Basic Helix-Loop-Helix Transcription Factors 0
Caenorhabditis elegans Proteins 0
HLH-30 protein, C elegans 0
Maleates 0
Peptides 0
Sequestosome-1 Protein 0
alpha-Synuclein 0
polyglutamine 26700-71-0
Glutathione Reductase EC 1.8.1.7
diethyl maleate G81WQB56OL
Glutathione GAN16C9B8O

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1545-1565

Références

Nat Cell Biol. 1999 May;1(1):45-50
pubmed: 10559863
Proc Natl Acad Sci U S A. 2001 Nov 6;98(23):13318-23
pubmed: 11687635
Proc Natl Acad Sci U S A. 2002 Aug 6;99(16):10417-22
pubmed: 12122205
J Cell Biol. 2003 Jun 9;161(5):845-51
pubmed: 12796474
Antioxid Redox Signal. 2005 Mar-Apr;7(3-4):348-66
pubmed: 15706083
J Neurosci. 2005 Apr 13;25(15):3801-12
pubmed: 15829632
FEBS Lett. 2006 Jan 23;580(2):484-90
pubmed: 16387300
Science. 2006 Mar 10;311(5766):1471-4
pubmed: 16469881
J Biol Chem. 2006 Nov 24;281(47):35608-15
pubmed: 16973603
Autophagy. 2007 Jan-Feb;3(1):21-5
pubmed: 17172799
Autophagy. 2007 Nov-Dec;3(6):569-80
pubmed: 17675890
WormBook. 2006 Apr 06;:1-32
pubmed: 18050450
WormBook. 2006 Feb 11;:1-11
pubmed: 18050451
Proc Natl Acad Sci U S A. 2008 Jan 15;105(2):728-33
pubmed: 18182484
Biochim Biophys Acta. 2008 Nov;1780(11):1273-90
pubmed: 18267127
PLoS Genet. 2008 Mar 21;4(3):e1000027
pubmed: 18369446
J Cell Biol. 2008 Jun 16;181(6):879-84
pubmed: 18541702
Antioxid Redox Signal. 2008 Nov;10(11):1941-88
pubmed: 18774901
Nature. 2009 Apr 16;458(7240):885-9
pubmed: 19287374
Cell Stress Chaperones. 2009 Nov;14(6):579-89
pubmed: 19291423
Science. 2009 Nov 27;326(5957):1208-12
pubmed: 19965462
PLoS One. 2010 Jan 19;5(1):e8774
pubmed: 20098744
J Cell Sci. 2010 Jun 15;123(Pt 12):2001-7
pubmed: 20519582
Cell. 2010 Jun 11;141(6):1042-55
pubmed: 20550938
Proc Natl Acad Sci U S A. 2011 Jan 18;108(3):1064-9
pubmed: 21199936
Hum Mol Genet. 2011 Aug 1;20(15):2996-3009
pubmed: 21546381
Science. 2011 Jun 17;332(6036):1429-33
pubmed: 21617040
Genome Biol. 2011 Jul 27;12(7):226
pubmed: 21867568
Antioxid Redox Signal. 2012 Jun 15;16(12):1384-400
pubmed: 22220943
Free Radic Biol Med. 2012 Mar 1;52(5):850-9
pubmed: 22226831
ASN Neuro. 2012 Apr 10;4(3):null
pubmed: 22376187
Proc Natl Acad Sci U S A. 2012 Jun 26;109(26):10587-92
pubmed: 22645345
J Toxicol. 2012;2012:546915
pubmed: 22899914
Mol Neurodegener. 2012 Nov 21;7:57
pubmed: 23171715
Antioxid Redox Signal. 2013 May 1;18(13):1699-711
pubmed: 23198979
Transl Neurodegener. 2012 Sep 26;1(1):19
pubmed: 23210724
Nat Rev Mol Cell Biol. 2013 Apr;14(4):237-48
pubmed: 23463216
PLoS One. 2013 Apr 08;8(4):e60731
pubmed: 23593298
Nat Cell Biol. 2013 Jun;15(6):668-76
pubmed: 23604316
Eur Neuropsychopharmacol. 2015 May;25(5):713-24
pubmed: 23642796
Nat Commun. 2013;4:2267
pubmed: 23925298
BMC Biol. 2013 Sep 30;11:100
pubmed: 24079614
Free Radic Biol Med. 2014 Mar;68:205-19
pubmed: 24316195
Antioxid Redox Signal. 2014 Jul 1;21(1):66-85
pubmed: 24483238
Antioxid Redox Signal. 2014 Jul 20;21(3):457-70
pubmed: 24483600
Redox Biol. 2014 Jan 30;2:323-32
pubmed: 24563850
Methods Cell Biol. 2014;122:277-310
pubmed: 24857735
PLoS Biol. 2014 Jun 24;12(6):e1001895
pubmed: 24960609
Semin Cell Dev Biol. 2014 Dec;36:121-9
pubmed: 25158238
Cell Death Differ. 2015 Mar;22(3):377-88
pubmed: 25257172
Nat Commun. 2014 Sep 29;5:5020
pubmed: 25262602
Nat Rev Neurol. 2014 Nov;10(11):620-33
pubmed: 25287597
Free Radic Biol Med. 2015 Feb;79:237-50
pubmed: 25289457
Cell. 2014 Oct 23;159(3):530-42
pubmed: 25417105
Autophagy. 2014;10(11):1953-64
pubmed: 25483965
Nat Commun. 2015 Mar 20;6:6479
pubmed: 25790857
Free Radic Biol Med. 2015 Jul;84:227-245
pubmed: 25843657
Nature. 2015 May 28;521(7553):525-8
pubmed: 25896323
Free Radic Biol Med. 2015 Nov;88(Pt B):199-204
pubmed: 26117325
Biochem J. 2015 Aug 1;469(3):347-55
pubmed: 26205490
EMBO J. 2015 Sep 14;34(18):2334-49
pubmed: 26228940
PLoS One. 2015 Aug 28;10(8):e0137032
pubmed: 26317626
Physiol Rev. 2016 Jan;96(1):307-64
pubmed: 26681794
Sci Rep. 2016 Apr 26;6:24933
pubmed: 27112200
Free Radic Biol Med. 2016 Jul;96:446-61
pubmed: 27117030
Worm. 2016 Mar 30;5(2):e1170273
pubmed: 27386166
PLoS Genet. 2016 Jul 14;12(7):e1006163
pubmed: 27415421
Sci Rep. 2016 Sep 22;6:33781
pubmed: 27653553
Bioessays. 2016 Dec;38(12):1246-1254
pubmed: 27790724
Redox Biol. 2017 Apr;11:502-515
pubmed: 28086197
EMBO J. 2017 Mar 1;36(5):693-702
pubmed: 28093500
Nature. 2017 Feb 16;542(7641):367-371
pubmed: 28178240
Redox Biol. 2017 Apr;11:708-714
pubmed: 28193593
Nat Commun. 2017 Feb 15;8:14337
pubmed: 28198373
Nature. 2017 Mar 16;543(7645):443-446
pubmed: 28241148
Elife. 2017 Jul 04;6:
pubmed: 28675140
Mol Cell. 2017 Sep 21;67(6):962-973.e5
pubmed: 28918898
Nat Commun. 2018 Jan 8;9(1):95
pubmed: 29311554
Nat Commun. 2018 Jan 17;9(1):256
pubmed: 29343728
Mol Neurobiol. 2018 Sep;55(9):7533-7552
pubmed: 29429047
Proc Natl Acad Sci U S A. 1995 Sep 26;92(20):9368-72
pubmed: 7568134

Auteurs

David Guerrero-Gómez (D)

Redox Homeostasis Group, Instituto de Biomedicina de Sevilla (IBIS), Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, 41013, Sevilla, Spain.

José Antonio Mora-Lorca (JA)

Redox Homeostasis Group, Instituto de Biomedicina de Sevilla (IBIS), Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, 41013, Sevilla, Spain.
Departamento de Farmacología, Facultad de Farmacia, Universidad de Sevilla, 41012, Sevilla, Spain.

Beatriz Sáenz-Narciso (B)

CIBIR (Center for Biomedical Research of La Rioja), 26006, Logroño, Spain.

Francisco José Naranjo-Galindo (FJ)

Redox Homeostasis Group, Instituto de Biomedicina de Sevilla (IBIS), Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, 41013, Sevilla, Spain.

Fernando Muñoz-Lobato (F)

Redox Homeostasis Group, Instituto de Biomedicina de Sevilla (IBIS), Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, 41013, Sevilla, Spain.

Cristina Parrado-Fernández (C)

Karolinska Institutet, Department of Neurobiology, Care Sciences and Society, Center for Alzheimer Research, Division of Neurogeriatrics, Stockholm, SE-14186, Sweden.

Julen Goikolea (J)

Karolinska Institutet, Department of Neurobiology, Care Sciences and Society, Center for Alzheimer Research, Division of Neurogeriatrics, Stockholm, SE-14186, Sweden.

Ángel Cedazo-Minguez (Á)

Karolinska Institutet, Department of Neurobiology, Care Sciences and Society, Center for Alzheimer Research, Division of Neurogeriatrics, Stockholm, SE-14186, Sweden.

Christopher D Link (CD)

Department of Integrative Physiology, Institute for Behavioral Genetics, University of Colorado at Boulder, Boulder, CO, 80309, USA.

Christian Neri (C)

Sorbonnes Université, Centre National de la Recherche Scientifique, Research Unit Biology of Adaptation and Aging (B2A), Team Compensation in Neurodegenerative and Aging (Brain-C), F-75252, Paris, France.

María Dolores Sequedo (MD)

Research Group in Molecular, Cellular and Genomic Biomedicine, Health Research Institute-La Fe, 46026, Valencia, Spain.
Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Valencia, Spain.

Rafael P Vázquez-Manrique (RP)

Research Group in Molecular, Cellular and Genomic Biomedicine, Health Research Institute-La Fe, 46026, Valencia, Spain.
Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Valencia, Spain.

Elena Fernández-Suárez (E)

Departamento de Genética, Facultad de Biología, Universidad de Sevilla, 41012, Sevilla, Spain.

Veit Goder (V)

Departamento de Genética, Facultad de Biología, Universidad de Sevilla, 41012, Sevilla, Spain.

Roser Pané (R)

Departament de Ciències Mèdiques Bàsiques, IRB Lleida, Universitat de Lleida, Av. Rovira Roure, 80, 25198, Lleida, Spain.

Elisa Cabiscol (E)

Departament de Ciències Mèdiques Bàsiques, IRB Lleida, Universitat de Lleida, Av. Rovira Roure, 80, 25198, Lleida, Spain.

Peter Askjaer (P)

Andalusian Center for Developmental Biology (CABD), CSIC/JA/Universidad Pablo de Olavide, 41013, Seville, Spain.

Juan Cabello (J)

CIBIR (Center for Biomedical Research of La Rioja), 26006, Logroño, Spain. juan.cabello@riojasalud.es.

Antonio Miranda-Vizuete (A)

Redox Homeostasis Group, Instituto de Biomedicina de Sevilla (IBIS), Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, 41013, Sevilla, Spain. amiranda-ibis@us.es.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH